vaccine patent waiver
U.S. support for waiving COVID-19 vaccine patent rights puts pressure on drugmakers
By Dalindyebo Shabalala, University of Dayton The U.S. and Europe are debating waiving patent rights for COVID-19 vaccines, a move that could allow more companies to produce the vaccine around the world. But it’s not as simple as it might sound. When the U.S. announced on May 5, 2021, that it supported the idea of […]